World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
48
Citations
9525
World Ranking
4663
National Ranking
6

Overview

Alejandro G. Schijman is affiliated with the National Scientific and Technical Research Council in Argentina. Their primary field of study is Medicine, encompassing 82 publications. Within Medicine, Schijman's work focuses on several specialized subfields, including Epidemiology, Public Health, Environmental and Occupational Health, Insect Science, Parasitology, and Organic Chemistry.

Schijman's research has concentrated extensively on parasitic diseases, specifically Trypanosoma species. This focus is reflected in major topical areas including Trypanosoma species research and implications, Research on Leishmaniasis Studies, Insect symbiosis and bacterial influences, Synthesis and Biological Evaluation, Parasitic Diseases Research and Treatment, Biochemical and Molecular Research, and Parasites and Host Interactions.

Notable recent papers authored or co-authored by Schijman include:

  • New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial, 2021, The Lancet Infectious Diseases
  • A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease, 2022, Clinical Infectious Diseases
  • Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus, 2020, PLoS neglected tropical diseases
  • Trypanosoma cruzi loop-mediated isothermal amplification (Trypanosoma cruzi Loopamp) kit for detection of congenital, acute and Chagas disease reactivation, 2020, PLoS neglected tropical diseases
  • New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia, 2021, BMJ Open

Schijman collaborates frequently with a network of researchers. Common co-authors include Joaquím Gascón, María-Jesús Pinazo, Julio Alonso-Padilla, Arturo Muñoz-Calderón, and Faustino Torrico.

Their work is published frequently in certain scientific journals, including:

  • PLoS neglected tropical diseases
  • Journal of Molecular Diagnostics
  • BMJ Open
  • Memórias do Instituto Oswaldo Cruz
  • The Lancet Microbe

The researcher's studies cover a broad range of topics related to parasitic infections and their treatment, diagnostic techniques, and epidemiological impacts, with a strong emphasis on Chagas disease and related treatments. The combination of clinical trials, diagnostic development, and epidemiological studies marks the multifaceted approach in their contributions to medical science and parasitology.

Best Publications

  • A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI.

    B Zingales;SG Andrade;Briones;DA Campbell

  • The revised Trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications.

    Bianca Zingales;Michael A. Miles;David A. Campbell;Michel Tibayrenc

  • International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients.

    Alejandro G. Schijman;Margarita Bisio;Liliana Orellana;Mariela Sued

  • Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in chagas disease patients.

    Tomás Duffy;Margarita María Catalina Bisio;Jaime Marcelo Altcheh;Juan Miguel Burgos

  • Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial.

    Faustino Torrico;Joaquim Gascon;Lourdes Ortiz;Cristina Alonso-Vega

  • Analytical performance of a multiplex Real-Time PCR assay using TaqMan probes for quantification of Trypanosoma cruzi satellite DNA in blood samples.

    Tomas Duffy;Carolina I. Cura;Juan C. Ramirez;Teresa Abate

  • Aetiological treatment of congenital Chagas’ disease diagnosed and monitored by the polymerase chain reaction

    Alejandro Gabriel Schijman;Jaime Marcelo Altcheh;Juan Miguel Burgos;Miguel Angel Biancardi

  • Towards a paradigm shift in the treatment of chronic Chagas disease

    R. Viotti;B. Alarcón de Noya;T. Araujo-Jorge;M. J. Grijalva

  • Direct molecular profiling of minicircle signatures and lineages of Trypanosoma cruzi bloodstream populations causing congenital Chagas disease

    Juan Miguel Burgos;Jaime Marcelo Altcheh;Margarita María Catalina Bisio;Tomás Duffy

  • Molecular Identification of Trypanosoma cruzi Discrete Typing Units in End-Stage Chronic Chagas Heart Disease and Reactivation after Heart Transplantation

    Juan Miguel Burgos;Mirta Diez;Carlos Vigliano;Margarita Bisio

  • Analytical Validation of Quantitative Real-Time PCR Methods for Quantification of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients

    Juan Carlos Ramírez;Carolina Inés Cura;Otacilio da Cruz Moreira;Eliane Lages-Silva

  • Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole.

    Gustavo Benaim;John M. Sanders;Yael Garcia-Marchán;Claudia Colina

  • Usefulness of PCR strategies for early diagnosis of Chagas' disease reactivation and treatment follow-up in heart transplantation.

    M. Diez;L. Favaloro;A. Bertolotti;J. M. Burgos

  • New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial

    Faustino Torrico;Joaquim Gascón;Fabiana Barreira;Bethania Blum

  • Trypanosoma cruzi I genotypes in different geographical regions and transmission cycles based on a microsatellite motif of the intergenic spacer of spliced-leader genes

    Carolina I. Cura;Ana M. Mejía-Jaramillo;Tomás Duffy;Juan M. Burgos

  • Identification of major Trypanosoma cruzi antigenic determinants in chronic Chagas' heart disease.

    Mariano J. Levin;Enrique Mesri;Richard Benarous;Gabriela Levitus

  • Molecular epidemiology of domestic and sylvatic Trypanosoma cruzi infection in rural northwestern Argentina.

    Marta Victoria Cardinal;Marta A. Lauricella;Leonardo A. Ceballos;Leonardo Lanati

  • Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity

    Bianca Zingales;Michael A. Miles;Carolina B. Moraes;Alejandro Luquetti

  • Chagas' disease diagnosis: a multicentric evaluation of Chagas Stat-Pak, a rapid immunochromatographic assay with recombinant proteins of Trypanosoma cruzi.

    Alejandro O. Luquetti;Carlos Ponce;Elisa Ponce;Javan Esfandiari

  • Congenital Chagas disease: Updated recommendations for prevention, diagnosis, treatment, and follow-up of newborns and siblings, girls, women of childbearing age, and pregnant women.

    Yves Carlier;Yves Carlier;Jaime Altcheh;Andrea Angheben;Hector Freilij

  • Sensitive and Specific Detection of Trypanosoma cruzi DNA in Clinical Specimens Using a Multi-Target Real-Time PCR Approach

    Yvonne Qvarnstrom;Alejandro Gabriel Schijman;Vincent Veron;Christine Aznar

Frequent Co-Authors

Mariano J. Levin
Mariano J. Levin University of Buenos Aires
Joaquim Gascon
Joaquim Gascon University of Barcelona
Ricardo E. Gürtler
Ricardo E. Gürtler University of Buenos Aires
Felipe Guhl
Felipe Guhl Universidad de Los Andes
Andrea M. Macedo
Andrea M. Macedo Universidade Federal de Minas Gerais
Uriel Kitron
Uriel Kitron Emory University
Bianca Zingales
Bianca Zingales Universidade de São Paulo
Mitermayer G. Reis
Mitermayer G. Reis Oswaldo Cruz Foundation
Igor C. Almeida
Igor C. Almeida The University of Texas at El Paso
Michel Tibayrenc
Michel Tibayrenc Institut de Recherche pour le Développement

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various interdisciplinary fields and career options. Many students consider expanding their expertise through online medical degrees, which offer flexible, accessible pathways into healthcare professions. These programs allow learners to balance studies with work or personal commitments while building a strong foundation in medical sciences.

Public health is another complementary area, especially for those interested in community health and epidemiology. There are numerous easy admission online MPH programs that provide practical skills for disease prevention and health promotion, ideal for microbiology graduates aiming to influence public health policy or research.

For students drawn to supporting children's emotional needs in healthcare settings, obtaining a CCLS certification can be a valuable step. This credential prepares professionals to improve pediatric patient experiences through specialized care and advocacy.

Importantly, many online programs are inclusive and accessible, including online colleges that accept felons. This inclusivity broadens opportunities for non-traditional students seeking to advance their education and careers in microbiology-related fields.

Best Scientists Citing Alejandro G. Schijman

Trending Scientists

Recently Published Articles